NasdaqGS:LIVNMedical Equipment
LivaNova (LIVN): Loss Reduction and Profitability Forecast Bolster Bull Case Despite Slower Revenue Growth
LivaNova (LIVN) remains in the red, but the company has made significant progress by narrowing its losses at an annual rate of 42.1% over the past five years. While margins failed to show improvement, investors are paying attention to an expected 32.89% earnings growth per year and the prospect of reaching profitability within three years, which would be well ahead of the broader market's pace.
See our full analysis for LivaNova.
Now, let’s see how these headline results compare to the...